Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	348	156	54	52	261	180
Market Cap Growth	362.57%	190.05%	2.84%	-79.89%	44.83%	102.61%
Enterprise Value	315	152	52	32	200	138
Last Close Price	4.15	3.20	2.29	5.11	31.10	26.50
PS Ratio	8478.52	3811.32	523.05	272.85	972.14	168.28
PB Ratio	21.15	-12.38	-4.13	-2.69	8.76	5.09
P/TBV Ratio	21.33	-	-	-	8.76	5.09
EV/Sales Ratio	7672.62	3696.61	505.85	166.19	747.51	128.96
Asset Turnover	0.00	0.01	0.01	0.01	0.01	0.03
Quick Ratio	1.85	0.33	0.27	0.37	2.11	5.65
Current Ratio	1.91	0.37	0.29	0.41	2.15	5.90
Return on Equity (ROE)	-1869.55%	-	-	-1220.38%	-174.03%	-85.13%
Return on Assets (ROA)	-152.73%	-546.48%	-349.18%	-105.65%	-72.11%	-41.69%
Return on Capital (ROIC)	-1165.74%	-	-	-710.48%	-108.87%	-53.48%
Earnings Yield	-16.26%	-35.99%	-96.24%	-119.54%	-21.75%	-12.83%
Buyback Yield / Dilution	-30.01%	-43.01%	-169.69%	-21.63%	-51.48%	-58.14%

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q